CorNova, a Burlington, MA-based developer of coronary stents with platinum surfaces, has raised $2.5 million of a proposed $6 million in equity financing, according to an SEC filing. The filing does not list the investors in the round, but peHUB writes that the firm’s previous investors include AdvanSource Biomaterials (formerly named CardioTech International) and Implant Sciences (AMEX:[[ticker:IMX]]), both of which are based in Wilmington, MA, as well as Siemens Venture Capital.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
